CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Biodexa Pharmaceuticals PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Biodexa Pharmaceuticals PLC
1 Caspian Point, Caspian Way
Phone: +44 1235841575p:+44 1235841575 ABINGDON, CF10 4DQ  United Kingdom

This company is no longer actively traded on any major stock exchange.

Business Summary
Biodexa Pharmaceuticals PLC, formerly known as Midatech Pharma PLC, is a United Kingdom-based drug delivery technology company. The Company is focused on improving the bio-delivery and bio-distribution of medicines. Its technologies include Biodexa Pharmaceuticals Q-Sphera, MidaCore and MidaSolve. Biodexa Pharmaceuticals Q-Sphera technology focuses on long acting injectables using proprietary 3D printing technology that encapsulates medicines into bioresorbable polymer microspheres with precision characteristics. Its technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202212/31/2021Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board Stephen B.Parker 63 6/20/2022 6/20/2022
Chief Executive Officer, Chief Financial Officer, Executive Director, Secretary Stephen A.Stamp 60 1/1/2021 9/9/2019
Chief Scientific Officer DmitryZamoryakhin 9/1/2021 9/1/2021
7 additional Officers and Directors records available in full report.

Business Names
Business Name
BDRX
Midatech Limited
Midatech Pharma (Wales) Limited
5 additional Business Names available in full report.

General Information
Outstanding Shares: 94,629,412 (As of 4/20/2023)
Stock Exchange: LON


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, September 27, 2023